Modified Cav1.4 Expression in the Cacna1fnob2 Mouse Due to Alternative Splicing of an ETn Inserted in Exon 2 by Doering, Clinton J. et al.
Modified Cav1.4 Expression in the Cacna1f
nob2 Mouse
Due to Alternative Splicing of an ETn Inserted in Exon 2
Clinton J. Doering
1,3., Renata Rehak
1., Stephan Bonfield
2,3, Jean B. Peloquin
1,3, William K. Stell
1,2,3,
Silvina C. Mema
4, Yves Sauve ´4, John E. McRory
1,3*
1Hotchkiss Brain Institute, University of Calgary, Calgary, Canada, 2Cell Biology and Anatomy / Surgery, University of Calgary, Calgary, Canada, 3Lions Centre for Retinal
Degeneration Research, University of Calgary, Calgary, Canada, 4Department of Ophthalmology, University of Alberta, Edmonton, Canada
Abstract
The Cacna1f
nob2 mouse is reported to be a naturally occurring null mutation for the Cav1.4 calcium channel gene and the
phenotype of this mouse is not identical to that of the targeted gene knockout model. We found two mRNA species in the
Cacna1f
nob2 mouse: approximately 90% of the mRNA represents a transcript with an in-frame stop codon within exon 2 of
CACNA1F, while approximately 10% of the mRNA represents a transcript in which alternative splicing within the ETn
element has removed the stop codon. This latter mRNA codes for full length Cav1.4 protein, detectable by Western blot
analysis that is predicted to differ from wild type Cav1.4 protein in a region of approximately 22 amino acids in the N-
terminal portion of the protein. Electrophysiological analysis with either mouse Cav1.4
wt or Cav1.4
nob2 cDNA revealed that
the alternatively spliced protein does not differ from wild type with respect to activation and inactivation characteristics;
however, while the wild type N-terminus interacted with filamin proteins in a biochemical pull-down experiment, the
alternatively spliced N-terminus did not. The Cacna1f
nob2 mouse electroretinogram displayed reduced b-wave and
oscillatory potential amplitudes, and the retina was morphologically disorganized, with substantial reduction in thickness of
the outer plexiform layer and sprouting of bipolar cell dendrites ectopically into the outer nuclear layer. Nevertheless, the
spatial contrast sensitivity (optokinetic response) of Cacna1f
nob2 mice was generally similar to that of wild type mice. These
results suggest the Cacna1f
nob2 mouse is not a CACNA1F knockout model. Rather, alternative splicing within the ETn
element can lead to full-length Cav1.4 protein, albeit at reduced levels, and the functional Cav1.4 mutant may be incapable
of interacting with cytoskeletal filamin proteins. These changes, do not alter the ability of the Cacna1f
nob2 mouse to detect
and follow moving sine-wave gratings compared to their wild type counterparts.
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Introduction
Influx of calcium through voltage-gated calcium channels
(VGCCs) leads to excitation-contraction coupling, excitation-
transcription coupling, neurotransmitter release, and programmed
cell death. Disorders of synaptic transmission are thought to be
instrumental in two forms of human X-linked congenital
stationary night blindness (CSNB): the ‘‘incomplete’’ form
(iCSNB, or CSNB2), in which rod- and cone-driven electroreti-
nogram (ERG) responses are reduced in amplitude, but oscillatory
potentials (OPs) can be recorded; and the ‘‘complete’’ form
(cCSNB, or CSNB1), in which rod-driven ERG responses are
greatly reduced or absent but cone-driven responses are relatively
well preserved, and OPs are rarely recorded. Mutations within the
CACNA1F gene coding for Cav1.4 L-type calcium channels have
been identified as one cause of CSNB2 [1,2], as well as X-linked
cone-rod dystrophy (CORDX3) [3] and A ˚land Island eye disease
[4]. Over seventy CSNB2 nonsense and missense mutations have
been identified (for example, [5–12], several of which have been
shown to alter the biophysical properties of the channels [13–19];
reviewed in [20]).
Knockout of CACNA1F protein in mice following insertion of a
self-excising Cre-lox-neo cassette into exon 7 results in an in-frame
premature stop codon (G305X) in the Cav1.4 protein [21]. These
Cacna1f
G305X mice are characterized by complete loss of the b-
wave and oscillatory potentials of the electroretinogram (ERG),
absence of cone-driven visually-evoked activity in the superior
colliculus, .90% reduction in calcium influx in photoreceptors,
and disrupted retinal morphology with loss of photoreceptor
synapses and sprouting of horizontal and bipolar cell dendrites
into the outer nuclear layer [21]. Cacna1f
G305X mice, therefore,
resemble CSNB1 patients in their lack of cone-driven functions.
More recently, a second mouse model said to be null for CACNA1F
has been described [22]. This Cacna1f
nob2 mouse arose by
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which is predicted to produce an in-frame premature stop codon.
Interestingly, while the Cacna1f
nob2 mouse also displays disrupted
retina morphology similar to that of the Cacna1f
G305X mouse, the
ERG of the Cacna1f
G305X mouse is more similar to that of CSNB2
patients, being characterized by a reduced b-wave and oscillatory
potentials while cone-driven responses are maintained.
The ETn element responsible for the Cacna1f
nob2 mouse belongs
to a family of early retrotransposons, approximately 5600 base
pairs in length, which are transcribed during embryogenesis [23–
25]. While they often are a source of mutations by insertion into
the coding frame of genes, their characteristic long terminal repeat
regions allow them to be alternatively spliced. This property can
result in transcription of the gene into which they were inserted, at
reduced levels [26,27]. We hypothesized that the difference in
phenotypes of the two mouse models was the result of alternative
splicing of the ETn element, which would allow some transcription
and synthesis of Cav1.4 protein. We have found two mRNA
species in the Cacna1f
nob2 mouse, one of which encodes an in-frame
stop codon, and another in which the stop codon is missing as a
result of splicing within the ETn; as a result, full-length protein was
detectable by Western blotting using an antibody raised against
the C-terminus of the a1F channel subunit (Cav1.4) protein. The
alternatively spliced protein did not differ from the wild type
protein with respect to activation and inactivation characteristics
in an expression system; however, unlike the wild type protein N-
terminus, the alternatively spliced N-terminus did not bind to
cytoskeletal filamin proteins. Interestingly, while the outer retinal
layers of the Cacna1f
nob2 mouse were significantly disorganized, the
optokinetic response was not dramatically different from that of
wild type mice.
Results
Two mRNA species are detected in the Cacna1f
nob2
mouse
Total RNA from the eyes of Cacna1f
wt and Cacna1f
nob2 mice was
analyzed by RT-PCR. As shown in Figure 1.B, while only a single
band was detected in Cacna1f
wt mice with either primer
combination (RR44+RR 45, or RR44+RR46), two bands were
detected in Cacna1f
nob2 mice (see table 1 for primers). Using the
fluorescence intensity of the bands to assess relative quantity, we
estimated that ,90% of the mRNA is accounted for by the larger
(Mr) band, and ,10% by the smaller (Mr) band (consistent results
from three separate reactions/gels). The cDNA bands were
subsequently isolated and sequenced; the larger and more intense
band corresponded to the CACNA1F-encoding sequence con-
taining the ETn transposable element with an in-frame stop codon
(Figure 2A), whereas the smaller and less intense band corre-
sponded to the CACNA1F-encoding sequence containing the
shorter ETn element that lacks the in-frame stop codon
(Figure 2B). Genotyping of these mice, along with genomic
DNA samples purchased from Jackson Laboratory, confirmed that
our Cacna1f
nob2 mice were identical in genotype to the original
Cacna1f
nob2 mouse line, as described previously [22]. An alignment
of the predicted protein sequences corresponding to wild type
Cav1.4 (hereafter referred to as Cav1.4
wt) and Cav1.4 from the
smaller size band (hereafter referred to as Cav1.4
nob2) is provided
in Figure 2C.
To test for Cav1.4 protein in the Cacna1f
nob2 mouse, we probed
lysates from spleen with a Cav1.4-specific antibody [16]. As shown
in Figure 3, a band near 230 kDa was detected in samples from
both Cacna1f
wt and Cacna1f
nob2 mice, but not from Cacna1f
G305X
mouse. A lower-Mr band (,150 kDa) was also detectable in
extracts from all mouse strains tested, except Cacna1f
G305X; this
band likely is a truncated form of the wild type protein, as is
characteristic of other L-type calcium channel proteins [28].
Cacna1f
nob2 mouse has a selective b-wave defect
These results indicated that a full-length Cav1.4 channel
(corresponding to the mRNA sequence from the smaller Mr, less
intense band in Figure 1B) could be present in the Cacna1f
nob2
mouse. This was surprising, since this mouse was reported to be
null for the Cav1.4 channel protein [22]. Therefore, we next tested
to ensure that the ERGs in our mice were identical to those
previously published.
ERG recordings showed a selective b-wave defect in Cacna1f
nob2,
compared with that in age-matched Cacna1f
wt mice (Figure 4), as
previously reported [22,29]. Under both scotopic and photopic
adaptation conditions, the amplitude of the b-wave was selectively
diminished. The intensity-response curves for the scotopic a-wave,
as well as maximal a-wave amplitudes and thresholds (minimum
luminance to reach criterion amplitude of 20 mV), were
comparable in our mutant and wild type mice. In contrast,
however, the b-waves in mutant and wild type mice were very
different. The proportion of maximal b-wave remaining in
Cacna1f
nob2 compared with age-matched Cacna1f
wt was statistically
significantly greater (p,0.05, U-test) under scotopic (0.5160.11)
than under photopic (0.2960.19) conditions. A typical way to
document selective b-wave loss, clinically, is to compare the b/a
ratios with values from control subjects: lower ratios mean selective
b-wave defects. There was a statistically significant decrease in b/a
ratios in mutant compared to wild type mice. The reductions in b/
a ratios were more pronounced under photopic (0.9960.19 in
Cacna1f
nob2 compared with 3.5860.81 in Cacna1f
wt;p ,0.05, U-test)
than scotopic conditions (0.8860.05 in Cacna1f
nob2 compared to
1.9460.09 in Cacna1f
wt;p ,0.05, U-test). In addition, the threshold
was higher in Cacna1f
nob2 mice under scotopic as well as photopic
conditions, and the photopic thresholds in Cacna1f
nob2 mice were
significantly higher than the scotopic thresholds. One b-wave
property that was not affected in the Cacna1f
nob2 mice compared
with Cacna1f
wt mice was the intensity at which maximal b-wave
amplitudes were attained. Finally, while we did not systematically
quantify the amplitudes of ERG oscillatory potentials, qualitatively
they were depressed in Cacna1f
nob2 as compared with those in
Cacna1f
wt mice.
Upon histological examination, we found that the structure of
retinas from Cacna1f
nob2 was disorganized compared to that of
Cacna1f
wt mice, with substantially reduced outer plexiform layer
thickness and dendritic sprouting of second-order neurons into the
outer nuclear layer (data not shown). These findings are consistent
with those reported previously in the original Cacna1f
nob2 mouse
strain [22,30].
Cacna1f
nob2 and Cacna1f
wt optokinetic responses (OKR)
are similar
Given that our Cacna1f
nob2 mice produced mRNA capable of
encoding full-length Cav1.4 calcium channels (albeit at reduced
levels, with only ,10% of the mRNA encoding full-length Cav1.4
protein) but still had defects in ERG and retinal structure, it was
important to test the consequences of these deficits for vision.
Therefore we assessed the ability of the mouse to track moving
sine-wave gratings.
All Cacna1f
nob2 mice tested showed robust optokinetic (more
correctly, head-turning or optocollic) responses to moving sine-
wave gratings, over a wide range of drift velocities and spatial
frequencies (Table 2; Figure 5). Their contrast sensitivities (CS)
were maximal at V=12 degrees/second (d/s), at all spatial
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at V=12 d/s were identical in litters 2 and 3; CS was maximal at
0.061 cycles/degree (c/d), and declined precipitously at spatial
frequencies above 0.2 c/d but more gradually at spatial
frequencies below 0.061 c/d. In litter 1, however, CS was
maximal at 0.1 c/d and was substantially lower than that of litters
2 and 3 at most spatial frequencies tested (Figure 5). The lower
limit of spatial frequencies that the animals could follow was
0.019–0.031 c/d, and the upper limit (‘‘acuity’’) was 0.275 c/d, in
all three litters. There was no significant difference between the
contrast sensitivities of litters 2 and 3 (P.0.05; Student-Neuman-
Keuls Multiple Comparisons Test), whereas the contrast sensitivity
of litters 2 and 3 (at V=12 d/s) differed significantly from that of
litter 1 (both P,0.001) at most spatial frequencies.
The contrast sensitivities of Cacna1f
wt mice were maximal at
V=12 d/s, at all spatial frequencies tested (data for other
velocities not shown). The CS function at V=12 d/s was similar
to that of Cacna1f
nob2 litters 2 and 3 at 0.031–0.1 c/d, but contrast
sensitivity remained high at 0.2 c/d and declined precipitously
only at spatial frequencies $0.275 c/d (Figure 5). The upper limit
of spatial frequencies that could be followed by Cacna1f
wt mice was
0.4 c/d, or ,1.56the acuity of Cacna1f
nob2 mice. The diminished
contrast sensitivity seen in the one litter (#1) of Cacna1f
nob2 mice
has not been seen in any WT mice, regardless of litter or age (S.P.
Bonfield, unpublished results).
Biophysical properties of Cav1.4
wt and Cav1.4
nob2
channels are statistically indistinguishable
Next, we tested whether the Cav1.4
nob2 channel could support
ionic currents. Standard whole-cell electrophysiological recordings
Figure 1. RT-PCR analysis of Cacna1f
wt and Cacna1f
nob2 mice. A. Schematic representation of the location of PCR primers used. Primers RR44,
45, and 46 were used for RT-PCR reactions; primers RR50, 51, 52, and 53 were used for genomic PCR reactions. B. Agarose gel depicting RT-PCR
reaction products for mRNA isolated from Cacna1f
wt and Cacna1f
nob2 mice. Regardless of the primer pair used, only a single band is detected using
mRNA from Cacna1f
wt mice. Using mRNA from Cacna1f
nob2 mice, however, two bands are visible (see arrows). The relative intensities of the
fluorescence signals indicate that the larger-Mr band accounts for ,90%, and the smaller-Mr band for ,10%, of the total mRNA.
doi:10.1371/journal.pone.0002538.g001
Table 1. Primer sequences.
Primer Name Primer Sequence (59R39) Primer Use
RR44 atgtcggaatctgaagtcgg RT-PCR (Figure 1A)
RR45 caatgctgatgcaggaccg
RR46 gcagtgttggagtcgtcctc
CDRR69 ggatccaaatgtcggaatctgaagtcg N-terminus amplification
CDRR70 gaattctcacttccactctacaatgctcatgc
doi:10.1371/journal.pone.0002538.t001
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wt and Cacna1f
nob2 mice. A. Sequencing results from the larger-Mr, more intense band. Sequences are
given for the DNA (small letters) and corresponding protein (capital letters); the sequence corresponding to wild type Cav1.4 protein is highlighted in
grey. The ETn transposable element is inserted after the ninth Cav1.4 amino acid, and encodes an in-frame stop codon (highlighted in red) which is
predicted to result in truncation of the Cav1.4 protein after only 25 amino acids. The underlined ETn sequence highlights a repetitive sequence
(compare to the beginning of the ETn sequence, beginning at amino acid number 4). B. Same as A., but for the smaller-Mr, less intense band. Note
that the inserted ETn element is shorter, and the in-frame stop codon is missing. C. Alignment of the predicted N-terminal amino acid sequences of
wild type Cav1.4 protein and Cav1.4 protein encoded in the smaller-Mr band. A region of approximately 22 amino acids differs in the N-termini of the
two clones.
doi:10.1371/journal.pone.0002538.g002
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wt
or Cav1.4
nob2 (along with rat b2a and a2–d1) constructs. With
20 mM Ba
2+ as charge carrier, the average activation and
inactivation parameters for Cav1.4
nob2 were not significantly
different from those of Cav1.4
wt (p.0.05, t-test; Table 3; Figure 6).
Also, with 2 mM Ca
2+ as the charge carrier and using ramp
protocols [31,32], no differences were observed in the activation
properties between the two clones (see inset, Fig 6).
The Cav1.4
wt N-terminus contains a putative site for phosphor-
ylation by mitogen-activated protein (MAP) kinase that is not
present in Cav1.4
nob2 (serine residue in PEPSPAN region of wild
type clone (Figure 2C) identified by ELM – Functional Sites in
Proteins, http://www.elm.eu.org). To test whether this predicted
phosphorylation site is differentially phosphorylated, thereby
causing a functional difference between the two clones, we
blocked MAP kinase activity in serum-starved cells by treating
them for 2 hours with 20 mM PD98059 (a specific inhibitor for
MAP kinase kinase; e.g., [33,34]). PD98059 did not significantly
alter the biophysical properties of either Cav1.4
wt or Cav1.4
nob2
channels (p.0.05) in comparison with those that were recorded in
the absence of the inhibitor (Table 3).
N-terminus from Cav1.4
wt and not Cav1.4
nob2 can interact
with filamin proteins
To test whether Cav1.4
wt and Cav1.4
nob2 constructs differen-
tially interact with cellular proteins, we utilized a biochemical pull-
down assay. As shown in Figure 7A, a band of approximately
37 kDa was pulled down by Cav1.4
wt but not Cav1.4
nob2 N-
termini. This band was excised, and the protein was subsequently
identified as filamin A by means of LC/MS/MS.
To investigate these interactions further, both -N-termini and
filamin proteins were used as biochemical pull-down ligands.
Filamin A and filamin B constructs with an HA tag were mixed
with the GST- Cav1.4
wt and GST-Cav1.4
nob2 lysates. As shown in
Figure 7B, the N-terminus of the Cav1.4
wt channel protein
interacted with the C-termini of both filamin A and filamin B,
whereas the N-terminus of the Cav1.4
nob2 channel protein did not.
Discussion
Taken together, our results suggest that alternative splicing
within the ETn element inserted into exon 2 of the CACNA1F
gene of the Cacna1f
nob2 mouse allows for full-length Cav1.4 protein
to be produced, and therefore this mouse model is not null for the
Cav1.4 calcium channel. These results contrast with those
previously published [22].
Because of their highly repetitive sequence, transposable
elements have previously been shown to undergo alternative
splicing; this allows for full-length protein to be produced, albeit at
reduced levels relative to those in WT controls [26,27]. In
agreement with these previous findings (depicted in Figure 1B), we
detected differentially spliced mRNA isoforms in the Cacna1f
nob2
mouse, with approximately 90% of the mRNA expected to be
transcribed to Cav1.4 protein having a premature stop codon in
exon 2, and 10% of the mRNA expected to be transcribed to full-
length channel protein with a mutated N-terminus (Figure 2C).
Full-length protein was detected in spleen samples with Western
blots (Figure 3), confirming that the alternatively spliced mRNA
species is capable of producing Cav1.4 channel proteins with a
molecular mass of ,230 kDa. We attempted to detect Cav1.4
channel protein in sections of mouse retina; however our antibody
is directed against the C-terminus of the human protein, which
shares only ,50% sequence homology with the mouse protein
(rendering the antibody only weakly cross-reactive and therefore
unsuitable for immunohistochemistry in mouse). Therefore, it was
necessary to use concentrated protein lysates from spleen on
Western blots, where Cav1.4 protein appears to be greatly
enriched [16]. While it is possible no functional Cav1.4 protein
is present in the Cacna1f
nob2 mouse retina, the reduced protein
levels in the retina may have accounted for the apparent
background labeling in previous reports (for example, the faint
labeling in Figure 1b from Chang et al., 2006). Thus, the CSNB2
phenotype in the Cacna1f
nob2 mouse could arise simply from
reduced Cav1.4 protein levels, rather than complete knockout of
protein. This hypothesis is supported by previous studies, which
have shown that R508Q and L1364H mutations of CACNA1F
linked to CSNB2 reduce the amount of functional protein in the
membrane, without significantly altering the biophysical proper-
ties of the channel [15].
Since our findings differ substantially from those reported
previously [22], it was necessary to ensure that the CACNA1F gene
mutation in the Cacna1f
nob2 mouse line that we were testing was the
same as that originally described. Therefore, we sequenced
genomic DNA, obtained both from our in-house colony and as
supplied by the Jackson Laboratory. In both cases the genomic
sequence confirmed the presence of the ETn element inserted into
exon 2 of the CACNA1F gene. Additionally, the mice we tested
showed alterations in the ERGs (Figure 4) that were consistent
with previous findings [22,30]. Taken together, these results
suggest that the CACNA1F gene mutation in the mice we were
testing was identical to that in the line originally described, and
that the inherited defect in our colony was not the result of a
random genetic mutation or a deletion of the ETn element from
exon 2.
As shown in Figure 4, the Cacna1f
nob2 mouse retina is
characterized by a functional defect that selectively affects the
light-driven activation of neurons in the inner retinal layers; this is
supported by the depression of the ERG b-wave (reflecting
diminished modulation of activity in depolarizing bipolar cells),
while the a-wave amplitudes are unaffected (indicating that
photoreceptor activity is relatively unaffected). The partial
preservation of the b-wave in these mice is reminiscent of the
Figure 3. Western blot of spleen samples from Cacna1f
wt,
Cacna1f
nob2, and Cacna1f
G305X mice probed with a Cav1.4-specific
antibody directed against the C-terminus of the channel. Full-
length protein is visible in all lanes except for Cacna1f
G305X.
doi:10.1371/journal.pone.0002538.g003
Altered Cav1.4 Expression
PLoS ONE | www.plosone.org 5 July 2008 | Volume 3 | Issue 7 | e2538Figure 4. ERG results showing selective inner retina defect in Cacna1f
nob2 mice. Representative ERG traces of responses obtained at various
intensities under scotopic (panel A) and photopic (panel B) adaptation are given for a Cacna1f
wt (left column) and an age-matched (52 days)
Cacna1f
nob2 mouse (right column); numbers on left of the traces correspond to the luminances (log cd/m
2) of the flashes that elicit these responses;
arrows point to the b-wave apex. Corresponding amplitudes of the a-wave and b-wave under scotopic conditions are shown in panels C and D,
respectively; and of b-wave amplitudes under photopic conditions are shown in panel E. Finally, examples of comparisons of responses obtained
from Cacna1f
wt and Cacna1f
nob2 are illustrated by superimposing the respective traces obtained from these two mouse types. Responses to high-
intensity stimuli (1.89 cd/m
2) are shown in panels F (scotopic adaptation) and G (photopic adaptation), and responses to low-intensity stimuli are
shown in panels H (20.81 cd/m
2 under scotopic adaptation) and I (0.38 cd/m
2 under photopic adaptation).
doi:10.1371/journal.pone.0002538.g004
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in contrast to the complete absence of a recordable b-wave in the
complete form of CSNB (CSNB1; [35,36]. As previously reported
in Cacna1f
nob2 mice, CACNA1F mutations in humans cause ERG b-
wave reductions under both dark-adapted (scotopic) and light-
adapted (photopic) conditions. Another similarity between Cac-
na1f
nob2 mice and CSNB2 patients is the depression of the OPs
under scotopic conditions. Finally, both humans with CACNA1F
mutations and Cacna1f
nob2 mice have normal photopic and scotopic
a-wave amplitudes [35,36], (Figure 5). There is evidence that
decreases in b-wave amplitude might lead to increases in a-wave
amplitudes. For instance, pharmacological blockade of mGluR6
receptors (with intravitreal injections of L-glutamate or APB) does
completely abolish the b-wave (also known as PII) and reveal
photoreceptor activity (also known as PIII) over its full time course,
and does increase the amplitude of the a-wave/PIII. However, in
cases of complete b-wave loss due to nyctalopin mutations, a-wave
amplitudes are normal under both scotopic and photopic
adaptation. So the outcome, whether b-wave reductions affect a-
wave amplitudes, might depend on the mechanism by which the
b-wave is abolished or decreased in amplitude. The possibility that
the mutated Cav1.4 channel might lead to reduced a-wave
amplitudes, and that these reductions might be compensated by
the indirect effect of increased a-wave amplitudes due to reduced
b-wave amplitudes, does exist, but we have no experimental
evidence to verify whether this is the case.
Previously, Cacna1f
nob2 mice were found to have a reduced b-
wave, and morphological studies of the Cacna1f
nob2 retina showed a
reduced OPL thickness and sprouting of second-order neurons
into the ONL. Therefore, we expected that the visual performance
of Cacna1f
nob2 mice would be greatly reduced or absent, as in
Cacna1f
G305X mice [37]. Quite unexpectedly, our Cacna1f
nob2 mice
responded robustly to a full range of sine-wave gratings, showing
only slight differences from the optokinetic performance of WT-
C57/BL6 mice. The major difference in visual performance of the
best-performing Cacna1f
nob2 mice was that their CS functions cut
off more sharply than those of Cacna1f
wt mice at spatial frequencies
$0.2 c/d, resulting in an optokinetic acuity of 0.275 c/d (Figure 6;
Table 2). As a result, the spatial acuity of Cacna1f
nob2 mice is about
two-thirds of the acuity of C57BL6 mice, which is 0.4 c/d [37].
Thus, our behavioral results show that the Cacna1f
nob2 mouse has
good vision (at least for the optokinetic response), despite its severe
ERG phenotype and morphologically abnormal outer retina. The
relatively good vision of Cacna1f
nob2 mice contrasts starkly with the
lack of optokinetic responses in a targeted CACNA1F knockout, the
G305X mutant [37], suggesting that the Cacna1f
nob2 phenotype is
not due solely to a truncation or loss-of-function mutation. Since
our Cacna1f
nob2 animals perform nearly as well as wild type
controls, it is clear that in spite of the histological and
electroretinographic evidence of severe retinal dysfunction, the
Cacna1f
nob2 mouse maintains at least some nearly normal visual
processing in proximal levels of the retina. Our finding that about
10% of whole-retinal Cacna1f
nob2 mRNA is expected to encode a
full-length channel protein similar to the wild type (whereas 90%
carries the in-frame stop codon) raises the question whether every
photoreceptor cell makes 10% WT-like protein, or 10% of
photoreceptor cells make 100% wild type-like protein (or some
combination of these). On the one hand, the loss of synapses in the
OPL and the sprouting of dendrites into the ONL point to
significant defects in the synthesis of Cav1.4 protein, and
consequently of transmitter release, in the vast majority of
photoreceptor cells; this suggests that nearly all Cacna1f
nob2
photoreceptor cells are making insufficient amounts of functional
channel protein. On the other hand, the retention of normal
contrast sensitivity and near-normal optokinetic acuity under
photopic conditions indicates that cone pathways are only
minimally affected. We suggest, therefore, that the wild type-like
transcript is expressed mainly or exclusively in cone photorecep-
tors, accounting for the relative sparing of cone transmission as
seen in the optokinetic response, and that the mutant transcript is
Figure 5. Optokinetic spatial contrast-sensitivity functions for
three different Cacna1f
nob2 litters and one Cacna1f
wt litter. Mean
contrast sensitivities6standard deviation, at drift velocity (V)=12 de-
grees per second (d/s) and various spatial frequencies (SF) in cycles per
degree (c/d). See Table 2 for further details and statistics.
doi:10.1371/journal.pone.0002538.g005
Table 2. Optokinetic Response Data for Cacna1f
nob2 and Cacna1f
wt mice.
Group (n)
Optimum spatial
freq. @ V=12 d/s
Threshold Contrast
(%) at Optimum
Contrast Sensitivity
at Optimum
Mean Difference
( 0.061 c/d; V=12 d/s) P (2-tailed t-test)
nob2 - Litter#1 (6) 0.1 c/d 13.39% 7.47 N/A ——
0.061 c/d 25.9% 3.86 212.038 vs Litter #3; ,0.001 (highly significant)
10.458 vs Litter #2 ,0.001 (highly significant)
nob2 – Litter#2 (4) 0.061 c/d, 6.3% 15.9 21.58, vs Litter #3 .0.05*
nob2 – Litter #3 (5) 0.061 c/d, 7.0% 14.32 See above ——
nob2 -Combined
Litters#(2+3) (9)
0.061 c/d, 6.7% 15.08 (averaged) N/A ——
WT (C57/BL6) (6) 0.061 c/d, 6.3% 15.9 0.88 vs Litters(2+3) 0.3454
doi:10.1371/journal.pone.0002538.t002
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for the striking loss of synaptic terminals and consequent thinning
in the OPL. The discrepancy, between retention of cone function
in the optokinetic response and loss of cone signals in the ERG,
may be due to differential processing of cone information or
mutation-dependent changes in the retinal circuits responsible for
the OKR and ERG. The experiments that would be required to
test this hypothesis are beyond the scope of the present study.
While full-length Cav1.4 protein is produced (albeit at
presumably reduced levels) in the Cacna1f
nob2 mouse, the encoded
amino acid sequence differs from that in the wild type by
approximately 20 residues in the N-terminus of the protein
(Figure2C).AsshowninFigure6,theelectrophysiologicalproperties
of Cav1.4
nob2 are not significantly different from those of Cav1.4
wt
when expressed in tsA-201 cells, with either 20 mM Ba
2+ or 2 mM
Ca
2+ as charge carrier, suggesting that the differences between
Cacna1f
nob2 and Cacna1f
wt mice do not arise from changes in the
activation or inactivation characteristics of the Cav1.4 channels.
Interestingly, within the span of amino acids that differ between the
mutant and wild type proteins, the Cav1.4
nob2 channel sequence
lacks a putative MAP kinase phosphorylation site that is present in
the wild type protein. PD98059, a specific inhibitor of MAPKK, did
not have a differential effect on the biophysical properties of either
Cav1.4
nob2 or Cav1.4
wt, suggesting that the difference in biophysical
properties of these channels is not due to a difference in
phosphorylation within these 20 amino acids.
However, as shown in Figure 7, the mutant and wild type N-
terminal regions do differ in that they interact with different
proteins, since the N-terminal GST-fusion protein for the Cav1.4
wt
sequence pulls down filamin protein, whereas the Cav1.4
nob2
peptide does not. Filamins are a family of cytoskeleton proteins
(200–300 kDa) that regulate and crosslink filamentous actin. They
are highly sensitive to proteolysis, and numerous fragments of
varying size, from 10 kDa to 280 kDa, have been identified [38];
reviewed in [39]. Calpain 3 has been shown to cleave full-length
filamin A (,260 kDa), yielding one identified product of
,220 kDa [40]; the other cleavage product, which is expected
to have a molecular mass of ,40 kDa, thus may account for the
filamin fragment identified in Figure 7A. Additionally, several
previous studies have demonstrated that interactions of ion
channels with filamin proteins result in enhanced targeting of
the ion channels to the plasma membrane accompanied by
increased current densities, specifically for Kir2.1 (binds to C-
terminus of FLNA; [41]), Kv4.2 and Kv4.3 [42], and CFTR [43–
46]. In the case of Kv4.2, a proline-rich region of the channel was
identified as necessary for the interaction, with only four amino
acids (PTPP) required for binding [42]. In our case, the wild type
sequence of the 20 amino-acid region unique to the N-terminus of
Cav1.4
wt contains six proline residues, while that of Cav1.4
nob2
only contains one; furthermore, at the boundary of this region with
the downstream N-terminal sequence, the wild type clone has a
PGPP motif (recall PTPP motif for Kv4.2), while the Cav1.4
nob2
construct has an NRPP motif. While we did not map the exact
residues in this 20 amino acid region necessary for this interaction,
these data suggest that the CSNB2-like phenotype of the Cacna1f
nob2
mouse may result not only from lower Cav1.4-mediated calcium-
current densities, due to the diminished production of full-length
protein, but also to a failure of targeting of the mutant protein to the
plasma membrane, due to its inability to interact with filamin. Since
filamin proteins are present in most cell types, any effects on current
densities may be masked in our overexpression (transfected cell)
system, but such effects could be profound in the highly regulated
environment of photoreceptor cells.
Methods
Cacna1f
nob2 (AXB6/pgnJ, stock #001678) mice were purchased
from Jackson Laboratory (Bar Harbor, ME, USA). A colony was
established by breeding Cacna1f
nob2 mice with in-house C57BL/6
mice at the University of Calgary Health Sciences Animal Resource
Centre. One male Cacna1f
G305X mouse was obtained from Dr. N.T.
Bech-Hansen (University of Calgary). PCR was used to confirm the
genotypeofallthemiceusedinthisstudy.Allexperimentalprotocols
wereapproved by University of CalgaryAnimalCareCommittee, in
accordance with guidelines established by the Canadian Council of
Animal Care and the ARVO Statement for the Use of Animals in
Ophthalmic and Visual Research.
RT-PCR, splice variant generation, and genomic analysis
Total RNA was isolated from a whole mouse eye (minus lens),
using Trizol (Invitrogen). To synthesize cDNA, 5 mL of isolated
RNA was added to oligo-dT primers along with Superscript II
reverse transcriptase (Invitrogen) and incubated according to the
manufacturer’s instructions. To probe for CACNA1F transcripts,
corresponding primersweresynthesized flankingtheETn element in
exon 1 (RR44) and exon 2 (RR45) or exon 3 (RR46) (Table 1;
Figure 1A). For amplification, 2 mL of cDNA and Hot Start Taq
(Qiagen)wereusedaccordingtothemanufacturer’sinstructions,and
the reaction product was analyzed on a 1.5% agarose gel; DNA
bands were isolated using a gel extraction kit (Qiagen), cloned into
pGEM-T-easy (Stratagene), and then sequenced to confirm identity.
Full length mouse Cav1.4 cDNA (Cav1.4
wt; [47] was subcloned
into pCDNA3.1zeo, and the Cav1.4
nob2 splice variant was
synthesized using site-directed mutagenesis and Not I and Spe I
Table 3. Summary of biophysical properties of mouse Cav1.4
wtand Cav1.4
nob2 constructs recorded with 20 mM Ba
2+ as charge
carrier.
Vact (mV) Gmax (nS) S (mV) Erev (mV) Vinact (mV) z
Cav1.4
wt 2364 (11) 463( 1 1 ) 9 61 (11) 4466( 1 1 ) 218611 (11) 1.960.6 (11)
Cav1.4
nob2 2164 (13) 361 (13) 8.260.8 (13) 4566( 1 3 ) 222610 (12) 363 (12)
Cav1.4
wt (s.s.) 2166 (4) 463( 4 ) 9 61 (4) 4467( 4 ) 22269 (4) 2.060.6 (4)
Cav1.4
wt (s.s.+PD98059) 162 (4) 3.460.8 (4) 8.460.8 (4) 4664( 4 ) 21769 (4) 1.860.4 (4)
Cav1.4
nob2 (s.s) 2463 (4) 2.160.3 (4) 8.760.3 (4) 4166( 4 ) 22866 (4) 2.460.7 (4)
Cav1.4
nob2 (s.s.+PD98059) 2562 (5) 2.060.9 (5) 8.460.3 (5) 4166( 5 ) 21865 (5) 1.760.5 (4)
s.s. denotes serum starvation for 2 hours; no statistical difference is observed between mouse Cav1.4
wt and Cav1.4
nob2, or between the constructs when currents were
recorded in the absence or presence of 20 mM PD98059 following two hours of serum starvation (p.0.05, one-way ANOVA).
doi:10.1371/journal.pone.0002538.t003
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constructs were transfected into an expression system for
electrophysiological analysis (see below).
Biochemistry
For analysis of Cav1.4
wt or Cav1.4
nob2 expression by polyacryl-
amide gel electrophoresis, protein concentrations in spleen lysates
were determined using a DC protein assay kit (BioRad), and equal
total protein was loaded into each lane. Cav1.4 proteins were
detected using 0.7 mg of an affinity purified rabbit polyclonal anti-
Cav1.4 antibody (1:1000 dilution; [16]). The membranes were
then washed, incubated with secondary HRP-conjugated anti-rat
IgG antibody (1:5000 dilution, GE Healthcare) and detected using
standard ECL methods. Spleen lysate from a Cacna1f
G305X mouse,
Figure 6. Biophysical properties of Cav1.4
wt and Cav1.4
nob2 channels, coexpressed with b2a and a2–d1 subunits in tSA-201 cells. A.
Representative current waveforms for Cav1.4
wt (left) and Cav1.4
nob2 (right) recorded with 20 mM Ba
2+ external saline. Horizontal scale bars denote
25 ms, and vertical scale bars 25 pA. B. Average activation (filled symbols) and inactivation (hollow) symbols for Cav1.4
wt (squares) and Cav1.4
nob2
(circles) recorded with 20 mM Ba
2+ external saline. Average activation parameters from 11 Cav1.4
wt cells and 13 Cav1.4
nob2 cells are: Vact,
wt=2364 mV, Vact, nob2=2164 mV (n=13); Gmax, wt=463 nS and Gmax, nob2=361 nS; Swt=961 mV and Snob2=8.260.8 mV. These values are
stastically identical, and are summarized in Table 3. Average inactivation parameters from these cells are Vinact, wt=218611 mV and Vinact,
nob2=222610 mV, with a large fraction of non-inactivating current for both channels. These values statistically identical and are summarized in
Table 3. C. Average half-inactivation potentials for channels recorded with 2 mM Ca
2+ as charge carrier. Currents were substantially smaller than with
20 mM Ba
2+, but were distinguishable from background noise, and were obtained using a ramp protocol identical to that previously reported [31],
obtained by ramping voltage from 2100 mV to +100 mV over 500 ms. Values were Vact, wt=21768 mV (average peak current size 2964 pA) and
Vact, nob2=21766 mV (average peak current size 2963 pA). The shift observed with switching from 20 mM Ba
2+ to 2 mM Ca
2+ as external charge
carrier is similar to that we have previously reported for the human Cav1.4 channels [16].
doi:10.1371/journal.pone.0002538.g006
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prepared similarly as a negative control. For the Western blots, 4
separate experiments (n=4) were performed and revealed the
same results.
PCR was used to amplify the N-termini of mouse Cav1.4
wt and
Cav1.4
nob2 from their appropriate cDNA templates, using primers
CDRR69 (with incorporated BamHI restriction site; Table 1) and
CDRR70 (with incorporated EcoRI site, Table 1). The fragment
was ligated into the T-easy vector system (Promega). After the
PCR product sequence had been verified, the N-terminal
fragments were excised (BamHI, EcoRI) and subcloned into the
pGEX-5X-1 GST Fusion System (Pharmacia). The resulting
GST-fusion proteins were purified using glutathione sepharose
beads (Amersham) according to the manufacturer’s instructions. A
50 mL aliquot of beads was mixed with 20 mL eye or spleen lysate
overnight at 4uC (whole eyes minus lens, from 7 C57/BL6 mice,
were pooled and homogenized in 200 mL total volume; spleens
from these mice were pooled and homogenized in 1 mL total
volume), beads washed, and then proteins resolved on a 10%
polyacrylamide gel stained with Coomassie Brilliant Blue. These
experiments were performed 3 separate times (n=3) resulting in
identical results. Protein bands of interest were excised from the
gel, and the protein sequence was determined using LC/MS/MS
(Southern Alberta Mass Spectrometry Centre).
Mouse filamin cDNA was obtained from OpenBiosystems. PCR
was used to amplify (past repeat 23) and add an HA tag onto the C-
terminal regions of filamins A and B. Each fragment was ligated into
the T-easy vector system (Promega), the sequence was confirmed,
and the fragment was subcloned into the expression vector
pCDNA3.1neo. The resulting construct was transfected into tsA-
201 cells (transfection details below). After a two-day incubation the
cells were lysed on ice with lysis buffer (300 mM NaCl, 50 mM Tris
pH 7.5, 0.1% Triton X-100) containing a protease-inhibitor cocktail
(complete Mini EDTA-free, Roche). The lysate was incubated with
sepharoseG beads (Amersham)and Anti-HAHigh Affinityantibody
(Roche) at 4uC for 4 hours. The beads were then washed and
incubated with 1 ml of GST- Cav1.4
wt or GST- Cav1.4
nob2 cell
lysate, overnight at 4uC. The beads were washed again, and then
proteinswereresolvedusingPAGE(12%gel),transferredtoaPVDF
membrane, and probed with Anti-GST antibody (1:2000 dilution,
GE Healthcare). Finally the membranes were washed, incubated
with HRP-conjugated anti-rat-IgG antibody (1:5000 dilution, GE
Healthcare) and detected using standard ECL methods. These
experiments were performed 3 independent times (n=3) and had
the identical results.
Tissue culture and transfection
Culturing and transfection of tsA-201 cells via the calcium
phosphate method have been previously described by us in detail
[16]. Briefly, tsA-201 cells were maintained in DMEM supple-
mented with 10% FBS and 50 U/mL penicillin-streptomycin.
Cells were grown to 80% confluency (37uC, humidified, 5% CO2),
dissociated enzymatically (trypsin-EDTA), and then plated at 10%
confluency on glass cover slips. After recovering for 8 hours, cells
were transfected using standard calcium phosphate techniques (in
all cases 6 mg each of cDNA encoding mouse a1, rat b2a, and rat
a2–d1 subunits, and 1 mg pIRES transfection marker). Twelve
hours later, cells were washed with fresh media and then moved to
29uC (5% CO2, humidified) for two to three days before
evaluation by the whole-cell patch clamp technique.
Electrophysiology
Electrophysiological data were acquired using an Axopatch
200B amplifier (Axon Instruments, Union City, CA) linked to a
Figure 7. A. Representative Coomassie Brilliant Blue-stained
10% PAGE gel from three separate experiments. N-termini from
Cav1.4
wt or Cav1.4
nob2 were fused to glutathione S-transferase and
purified on glutathione beads. Lysates from eye (lanes D–F) or spleen
(G–I) were then incubated with the beads, and subsequently washed.
Unpurified eye or spleen lysates (5 mL) or purified beads+lysates (40 mL)
were loaded onto the gel. Lanes are as follows: A: unpurified eye, B:
unpurified spleen, C: protein ladder, D: glutathione-sepharose bead-
s+eye lysates, E: glutathione-sepharose beads+eye lysates+GST-Cav1.4
N-terminus, F: glutathione-sepharose beads+eye lysates+GST-Cav1.4
nob2
N-terminus, G: glutathione-sepharose beads+spleen lysates, H: gluta-
thione-sepharose beads+spleen lysates+GST-Cav1.4 N-terminus, I: glu-
tathione-sepharose beads+spleen lysates+GST-Cav1.4
nob2 N-terminus. A
prominent band of Mr slightly larger than 37 kDa is observed in lanes E
and H, but is absent from lanes F and I. This band was interpreted as a
filamin A protein fragment. B. GST-fused N-termini from Cav1.4
wt or
Cav1.4
nob2 were incubated with HA-tagged C-termini of filamin A or
filamin B. Only GST-Cav1.4
wt N-terminus was capable of interacting with
either filamin A or filamin B. Lanes 1-3 correspond to filamin A (with
GST-Cav1.4
wt,G S T - C a v 1 . 4
nob2, and GST, respectively); lanes 4–6
correspond to filamin B (with GST-Cav1.4
wt, GST-Cav1.4
nob2, and GST,
respectively); lanes 7 and 8 to filamin A and B, respectively (no GST
construct); lanes 9–11 GST-Cav1.4
wt, GST-Cav1.4
nob2, and GST, respec-
tively (with no filamin constructs); lane 12 is unpurified GST-Cav1.4
wt
lysate; lane 13 is unpurified GST-Cav1.4
nob2 lysate.
doi:10.1371/journal.pone.0002538.g007
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9.1 (Axon) software. In all cases, pipette capacitance and series
resistance were compensated (series resistance by 80%). Currents
were filtered at 1 kHz and digitized at 2 kHz. Prior to recording,
individual cover slips were transferred to a 3 cm culture dish filled
with bath recording solution (in mM: 20 BaCl2 (or 2 CaCl2 for
ramp protocols), 65 CsCl, 40 TEA-Cl, 1 MgCl2, 10 glucose, 10
HEPES, pH 7.20 with TEA-OH). Pipettes (BF-150-86 borosilicate
glass, Sutter Instruments, Novato CA) were pulled on a P-87
microelectrode puller (Sutter Instruments) and fire-polished with
an MF-830 microforge (Narishige, Japan) to a resistance of 1–
4M V when filled with recording solution (in mM: 108
CsCH3SO3, 4 MgCl2, 9 EGTA, 9 HEPES pH 7.20 with CsOH).
Current-voltage relations were obtained by holding cells at
2100 mV before stepping to various test potentials for 150 ms,
typically at a frequency of 0.2 Hz. Ramp experiments were
obtained by changing membrane voltage from 2100 mV to
+100 mV over 500 ms. Whole-cell current-voltage relations were
fitted with Equation 1, where I denotes peak current amplitude, V
is the test potential, Vact is the half-activation potential, S is a slope
factor, Gmax is maximum chord/slope (whole-cell) conductance,
and Erev is reversal potential.
I~
Gmax V{Erev ðÞ
1ze
Vact{V
S
ð1Þ
Inactivation-voltage relations were obtained by holding cells at
2100 mV, depolarizing to a test potential of +20 mV for 50 ms,
stepping back to 2100 mV for 1 ms before initiating a 10 s
conditioning pulse to various potentials, stepping back to
2100 mV for 1 ms, and initiating a second test pulse to
+20 mV for 50 ms. The degree of inactivation was determined
as the ratio of the second test pulse to the first test pulse.
Inactivation-voltage relations were fitted with Equation 2, where I
is the degree of inactivation, V is the conditioning potential, Vinact
is the half-inactivation potential, z is a slope factor reflecting
effective gating charge, and x represents the non-inactivating
fraction of current. Since experiments were typically carried out at
room temperature, R (universal gas constant), F (Faraday
constant), and T (absolute temperature) simplify to a value of
25.6 mV in this equation (ie. RT/F=25.6 mV).
I~xz
1{x
1ze
{zV inact{V ðÞ
25:6
ð2Þ
Electrophysiological data were analyzed using Clampfit9.1
software (Axon Instruments, Union City, CA) and SigmaPlot2000
(Jandel Scientific, Chicago, IL).
PD98059, a mitogen-activated protein (MAP) kinase inhibitor,
(Tocris Biosciences) was dissolved in DMSO at a stock
concentration of 25 mM, and then diluted into the final recording
solution immediately before recording. Control and test cells were
serum-starved for 2 hours in the presence or absence of inhibitor
(see for example, [34,48–50]) prior to electrophysiological analysis.
Control (with DMSO vehicle) and drug (20 mM) saline solutions
were delivered by a gravity-driven microperfusion system.
ERG recordings
ERGs were recorded from Cacna1f
nob2 (n=6) and age-matched
Cacna1f
wt (n=5) mice, as previously described [51]. Briefly, after
overnight dark-adaptation, mice were prepared for bilateral
recordings under dim red light. While under anesthesia (xylazine
10 mg/kg i.p; ketamine 150 mg/kg i.p.) the mouse body
temperature was monitored with a rectal probe and maintained
at 38uC using a homeothermic blanket. Both pupils were dilated
using 1% tropicamide. A drop of methylcellulose, applied on each
cornea, prevented dehydration and allowed electrical contact with
the recording electrode (gold wire loop). A pair of 25-gauge
platinum needles inserted subdermally behind each eye served as
reference electrodes. Amplification (1–1000 Hz bandpass), stimu-
lus presentation, and data acquisition were provided by the Espion
E 2 ERG system (Diagnosys LLC, Lowell, MA). First, scotopic
intensity-response functions were determined using single flashes
(6500K, 10 ms duration) presented to dark-adapted animals at
nineteen increasing intensity steps from 25.22 to 2.86 log cds/m
2.
The inter-stimulus-interval (ISI) was increased progressively from
5 sec (at the lowest stimulus intensity) to 2 minutes (at the highest
stimulus intensity), so as to minimize rod photopigment bleaching
and desensitization. The amplitude of the b-wave was measured
from the a-wave negative peak to the b-wave positive apex, and
not to the peak of oscillatory potentials (OPs), which can exceed
the b-wave apex [52]. After 10 min photopic adaptation (30 cd/
m
2 background), cone-driven intensity-response functions were
obtained, using single flashes (6500K, 10 ms duration) presented at
eleven increasing intensity steps from 21.63 to 2.86 log cds/m
2.
The time interval between steps was 10 seconds, and each stimulus
was presented 6 times at 5 sec intervals. Responses were averaged
for the six flashes at each intensity. For data analysis, responses
from both eyes were considered, therefore the values in the graphs
represent average6standard deviations for n=12 Cacna1f
nob2 and
n=10Cacna1f
wt eyes.
Optokinetic (Head-Turning or Optocollic) Responses.
Contrast sensitivity functions were obtained for optokinetic
responses to moving sine-wave gratings, using the virtual
optomotor apparatus, OptoMotry
TM (Cerebral Mechanics,
Lethbridge, AB, Canada; [53,54]). Briefly, three sets of Cacna1f
nob2
littermates of either sex (litter #1: n=6; litter #2: n=4; litter #3:
n=5), or their wild type background littermates(n=6), aged 90–110
days, were placed individually on a 5 cm platform mounted in the
middle of a closed testing chamber enclosed by four 17-inch LCD
computer monitors (model 1703FP; Dell, Phoenix, AZ). We
observed head-following responses by means of a digital video
camera mounted above the platform in the lid of the chamber.
Horizontally drifting sine-wave gratings, drifting to either the left or
right, were presented at various spatial frequencies (0.019 cycles/
degree (c/d) to 0.3 c/d) and drift velocities (6, 12, 18, 24, 30 and
36 degrees/second (d/s), for most spatial frequencies). Contrast
threshold, defined as the lowest contrast at which the animal could
follow the moving grating reliably (Michelson contrast: Equation 3,
whereLmax andLminarethemaximumandminimumluminancesof
themonitors),wasdetermined byamodified staircaseprocedureand
a two-alternative forced-choice paradigm. Contrast sensitivity was
defined as the inverse of contrast threshold (100/threshold %
contrast), and acuity was defined as the highest spatial frequency at
which the animal could follow the drifting grating at 100% contrast.
Mc~
Lmax{Lmin
LmaxzLmin
ð3Þ
Contrast, spatial frequency, and rotation velocity are expressed
here as the computer settings. True contrast and luminance at the
center of the animal’s viewing platform were measured with a
Minolta LS-110 Luminance Meter, operating as a spot photom-
eter with a 1 degree acceptance angle. The mean luminance was
55 cd/m
2 for a 1.0 c/d sine-wave grating of maximum contrast
moving at 12 d/s, and the mean luminances of ‘‘black’’ and
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mined with a stationary 0.011 c/d grating at 100% contrast, were
3.98 cd/m
2 and 104.2 cd/m
2, respectively. Thus, the actual
Michelson contrast range was 3.8–100%; contrast thresholds, and
the related contrast sensitivities reported in this paper, were not
corrected for this small discrepancy from the instrument’s contrast
settings of 0–100%. Mean luminance of the gratings varied from
27.5 to 110 cd/m
2 with distance from the monitor screens, as the
animal moved freely on the platform.
Statistics
Statistical analyses were performed using either SigmaStat2.03
(SSI, Richmond, CA), or Prism
TM or InStat
TM (GraphPad
Software Inc., San Diego, CA, USA). Unless otherwise stated,
numbers shown are mean6standard deviation, and numbers in
parentheses denote the number of experiments (=number of
animals tested). Significant differences are denoted by * (p,0.05).
For optokinetic responses, a one-way ANOVA (InStat
TM) was
used to determine whether significant differences existed among
the data gathered for the three litters.
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